The European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. With a total budget of around €375 million, provided by the EU and more than 50 international partners, EP PerMed will not only significantly support the transnational development of personalised medicine approaches over the next ten years, but also their successful translation into clinical practice.
In addition to funding personalised medicine research, EP PerMed will:
- Act as global personalised medicine platform for scientific and strategic dialogue and alignment.
- Facilitate and accelerate all steps of implementation through the full value continuum, so that personalised medicine achievements can be successfully implemented.
- Foster demonstration projects and promote successes and lessons learned to demonstrate evidence of personalised medicine implementation.
The Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM), developed by EP PerMed partners, is the basis for the partnership’s structure and a wide range of its activities.
The German Aerospace Center’s project management agency (DLR Projektträger) is coordinating the partnership.
